BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27935425)

  • 1. How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
    Silipo M; Gautrey H; Satam S; Lennard T; Tyson-Capper A
    RNA Biol; 2017 May; 14(5):536-543. PubMed ID: 27935425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
    Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
    RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells.
    Wan J; Sazani P; Kole R
    Int J Cancer; 2009 Feb; 124(4):772-7. PubMed ID: 19035464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer.
    Hart V; Silipo M; Satam S; Gautrey H; Kirby J; Tyson-Capper A
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2893-2912. PubMed ID: 34136934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.
    Koletsa T; Kostopoulos I; Charalambous E; Christoforidou B; Nenopoulou E; Kotoula V
    Neoplasia; 2008 Jul; 10(7):687-96. PubMed ID: 18592003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
    Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
    Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes.
    Pagano E; Fontana V; Calvo JC
    Mol Med Rep; 2011; 4(5):955-61. PubMed ID: 21720714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
    Chabot B; Blanchette M; Lapierre I; La Branche H
    Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense-mediated exon skipping to shift alternative splicing to treat cancer.
    Wan J
    Methods Mol Biol; 2012; 867():201-8. PubMed ID: 22454063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
    Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
    BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA.
    Kosaki A; Nelson J; Webster NJ
    J Biol Chem; 1998 Apr; 273(17):10331-7. PubMed ID: 9553088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.
    Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM
    Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
    Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
    J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
    Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
    Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.
    Choi N; Liu Y; Oh J; Ha J; Zheng X; Shen H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33317029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The architecture of pre-mRNAs affects mechanisms of splice-site pairing.
    Fox-Walsh KL; Dou Y; Lam BJ; Hung SP; Baldi PF; Hertel KJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16176-81. PubMed ID: 16260721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene.
    Russo A; Siciliano G; Catillo M; Giangrande C; Amoresano A; Pucci P; Pietropaolo C; Russo G
    Biochim Biophys Acta; 2010; 1799(5-6):419-28. PubMed ID: 20100605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.